No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Aged, 80 and over
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Autoimmunity
-
Diabetes Mellitus, Type 1 / blood
-
Diabetes Mellitus, Type 1 / chemically induced*
-
Diabetes Mellitus, Type 1 / immunology
-
Diabetes Mellitus, Type 1 / pathology
-
Disease Progression
-
Female
-
Humans
-
Immunotherapy / adverse effects*
-
Male
-
Middle Aged
-
Neoplasms / immunology
-
Neoplasms / therapy
-
Nivolumab
-
Programmed Cell Death 1 Receptor / immunology*
Substances
-
Antibodies, Monoclonal
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Nivolumab